JoeyPinkney.com Exclusive Interview
5 Minutes, 5 Questions With…
Rudy A. Mazzocchi, author of Equity of Evil
(Twilight Times Books)
A Venture Capital Fund makes a risky investment to start a challenging new business that appears capable of reaching profitability with modest capital requirements. The real challenge: optimizing one of the most frequently performed surgical procedures in the World — Abortion.
Founding Partner, Roman Citrano, a successful entrepreneur turned venture capitalist, soon struggles with what he believes is his choice to establish the controversial new company. He soon realizes that he and others are but pawns on a massive, ugly chessboard being manipulated to benefit a far larger, illicit market in human organs for transplantation. Unknowingly, prime, hyper-enriched organs are spawned from the aborted fetuses and grown like hydroponic vegetables.
Based on true events, this bold novel involves some of the world’s oldest, most emotional and controversial issues. At the core of each matter is man’s predisposition to control and take ownership of the human spirit for the sake of profit and personal gain… Such is the dark and brutal new world where life becomes the equity of evil.
Joey Pinkney: Where did you get the inspiration to write Equity of Evil?
Rudy A. Mazzocchi: As a serial entrepreneur and CEO of nearly a dozen med-tech/biotech companies, I’ve been privileged to work some of the most brilliant researchers and scientists in the world. This has introduced me to some of the most unbelievable and often “scary” medical innovations, sometimes nearly 8-10 years before they would ever be tested or commercialized in humans. By simply asking “why not” and “what if”, I realized that they had the makings of some phenomenal story-telling.
JP: What sets Equity of Evil apart from other books in the same genre?
RAM: Equity of Evil is based on many true events and real technologies that will force people to rethink some of their political, moral and ethical beliefs. This book is intended to open up the reader’s mind and heart to what may be coming in the very near future, whether we like it or not. Many of these new scientific breakthroughs will affect each and every one of us, if not our children or our grandchildren.
JP: As an author, what are the keys to your success that led to Equity of Evil getting out to the public?
RAM: Because I drew on personal experiences and over two decades of research, this book has become more than just a “medical thriller”. It combines medical, legal and business issues in one suspense (now award-winning) novel.
As I first-time author, I was fortunate to capture the interest of a Literary Agency (Trident Media Group) and Publisher (Twilight Times Books) which gave me credibility with several professional editors and eventually the Best-selling Author, Dr. Robin Cook who provided me with an excellent review and “blurb” for the front cover!
JP: As an author, what is your writing process? How long did it take you to start and finish Equity of Evil?
RAM: Equity of Evil took about a year to complete and nearly 6 more months of editing with two (2) professional editors; one who actually helped teach me the art of writing while he edited, and the other who helped with structural editing and format. It was released as an eBook another 6-9 months later (in March 2012) and then in print on July 15, 2012.
JP: What’s next for Rudy A. Mazzocchi?
RAM: I’ve been challenged with writing the proverbial “trilogy”, one called “The Equity Series”. This will carry a common theme, along with the participation of my main character from the first novel who will now become a “supporting character”. However, this 2nd novel will focus on another fascinating medical breakthrough known as “neuroplasticity” – the re-wiring of the brain to restore sight, memory, or even eliminate fear!
Rudy is best known as a medical device and biotechnology entrepreneur, inventor, and angel investor, with a history of starting new technology ventures throughout the U.S. and Europe. He’s been privileged to have the opportunity to see the newest innovations in healthcare and work with some of the most brilliant researchers, scientists and physicians in the industry.
Authoring more than 50 patents, he has helped pioneer new companies involved in cardiology, oncology, orthopedics, neurosurgery and even embryonic stem-cell development. Through these efforts, he has become the recipient of many technology and business awards, including the Ernst & Young Entrepreneur of the Year in Healthcare and the Businessman of the Year Award.
Combining these experiences and opportunities, with thousands of hours of travel and long evenings in hotel rooms, he found the initiative to start writing a collection of medical thrillers based on true events, the first of which is entitled EQUITY of EVIL.
2011 eLit Book Award (Suspense/Thriller)
2012 Award-winning Finalist for INDIE Book Award
2012 Global eBook Award (Suspense/Thriller)